Overview

Phase III Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients

Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine the safety and IOP-lowering ability of a glaucoma therapy in patients with open-angle glaucoma or ocular hypertension
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Alcon Research
Treatments:
Travoprost
Criteria
Inclusion Criteria:

- Adult subjects of either sex and any race 18 years or older with open-angle glaucoma
or ocular hypertension. Patients with logMAR visual acuity not worse than 0.6 in
either eye or any clinically relevant ophthalmic/systemic condition will be excluded.

Exclusion Criteria:

- See Inclusion Criteria